{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:28:07Z","timestamp":1768706887819,"version":"3.49.0"},"reference-count":41,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":125,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Italian Neuroblastoma Foundation"},{"name":"Italian Ministry of Health","award":["2010-2311890"],"award-info":[{"award-number":["2010-2311890"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1002\/pbc.25552","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T13:57:45Z","timestamp":1430315865000},"page":"1725-1732","source":"Crossref","is-referenced-by-count":34,"title":["Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma Group"],"prefix":"10.1002","volume":"62","author":[{"given":"Katia","family":"Mazzocco","sequence":"first","affiliation":[{"name":"Department of Pathology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Defferrari","sequence":"additional","affiliation":[{"name":"Department of Pathology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Rita","family":"Sementa","sequence":"additional","affiliation":[{"name":"Department of Pathology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Longo","sequence":"additional","affiliation":[{"name":"U.O.C. Bioterapie IRCSS A.O.U. San Martino-IST; Istituto Nazionale per la Ricerca sul Cancro; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"De Mariano","sequence":"additional","affiliation":[{"name":"U.O.C. Bioterapie IRCSS A.O.U. San Martino-IST; Istituto Nazionale per la Ricerca sul Cancro; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Esposito","sequence":"additional","affiliation":[{"name":"Neuroblastoma Laboratory; Onco\/Hematology Laboratory; SDB Department; University of Padova; Pediatric Research Institute; Fondazione Citt\u00e0 della Speranza; Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Negri","sequence":"additional","affiliation":[{"name":"Department of Pathology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Ircol\u00f2","sequence":"additional","affiliation":[{"name":"Department of Pathology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Viscardi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Padova; Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Luksch","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology; National Cancer Institute; Milano Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"D'Angelo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology; ARNAS Civico Di Cristina Benfratelli Hospital; Palermo Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[{"name":"Pediatric Oncology and Hematology Unit \u201cLalla Ser\u00e0gnoli\u201c; University of Bologna Sant'Orsola-Malpighi Hospital; Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Castellano","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology-Oncology; IRCCS; Ospedale Bambino Ges\u00f9; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Massirio","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Erminio","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Gigliotti","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Tonini","sequence":"additional","affiliation":[{"name":"Neuroblastoma Laboratory; Onco\/Hematology Laboratory; SDB Department; University of Padova; Pediatric Research Institute; Fondazione Citt\u00e0 della Speranza; Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Conte","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology; Istituto Giannina Gaslini; Genova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"10.1002\/pbc.25552-BIB0001|pbc25552-cit-0001","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00043426-199709000-00004","article-title":"Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992","volume":"19","author":"Gurney","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1002\/pbc.25552-BIB0002|pbc25552-cit-0002","unstructured":"Whelan SL Ferlay J 2003"},{"key":"10.1002\/pbc.25552-BIB0003|pbc25552-cit-0003","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<532::AID-CNCR22>3.0.CO;2-Z","article-title":"Trends in cancer incidence among children in the U. S","volume":"78","author":"Gurney","year":"1996","journal-title":"Cancer"},{"key":"10.1002\/pbc.25552-BIB0004|pbc25552-cit-0004","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/cncr.21751","article-title":"Neuroblastoma in adolescents: The Italian experience","volume":"106","author":"Conte","year":"2006","journal-title":"Cancer"},{"key":"10.1002\/pbc.25552-BIB0005|pbc25552-cit-0005","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature07397","article-title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","volume":"455","author":"George","year":"2008","journal-title":"Nature"},{"key":"10.1002\/pbc.25552-BIB0006|pbc25552-cit-0006","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Molenaar","year":"2012","journal-title":"Nature"},{"key":"10.1002\/pbc.25552-BIB0007|pbc25552-cit-0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/pbc.25552-BIB0008|pbc25552-cit-0008","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Moss\u00e9","year":"2008","journal-title":"Nature"},{"key":"10.1002\/pbc.25552-BIB0009|pbc25552-cit-0009","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-10-2809","article-title":"High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma","volume":"17","author":"Schulte","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0010|pbc25552-cit-0010","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1158\/1078-0432.CCR-09-2660","article-title":"Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification","volume":"16","author":"De Brouwer","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0011|pbc25552-cit-0011","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1158\/0008-5472.CAN-08-4419","article-title":"Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients","volume":"69","author":"Passoni","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0012|pbc25552-cit-0012","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1158\/0008-5472.CAN-07-6186","article-title":"Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors","volume":"68","author":"McDermott","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0013|pbc25552-cit-0013","unstructured":"Cheung NK Zhang J Lu C Parker M Bahrami A Tickoo SK Heguy A Pappo AS Federico S Dalton J Cheung IY Ding L Fulton R Wang J Chen X Becksfort J Wu J Billups CA Ellison D Mardis ER Wilson RK Downing JR Dyer MA 2012 307 1062 1071"},{"key":"10.1002\/pbc.25552-BIB0014|pbc25552-cit-0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(98)00122-0","article-title":"Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome","volume":"130","author":"Iolascon","year":"1998","journal-title":"Cancer Letters"},{"key":"10.1002\/pbc.25552-BIB0015|pbc25552-cit-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1096-911X(20010101)36:1<1::AID-MPO1002>3.0.CO;2-L","article-title":"Intratumoral heterogeneity of 1p deletions and MYCN amplification in neuroblastomas","volume":"36","author":"Ambros","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1002\/pbc.25552-BIB0016|pbc25552-cit-0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1046-2023(02)00061-0","article-title":"Methylation sequencing from limiting DNA: Embryonic, fixed, and microdissected cells","volume":"27","author":"Millar","year":"2002","journal-title":"Methods"},{"key":"10.1002\/pbc.25552-BIB0017|pbc25552-cit-0017","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/1078-0432.CCR-10-0830","article-title":"A multilocus technique for risk evaluation of patients with neuroblastoma","volume":"17","author":"Ambros","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0018|pbc25552-cit-0018","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ajpath.2011.12.003","article-title":"High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome","volume":"180","author":"Duijkers","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1002\/pbc.25552-BIB0019|pbc25552-cit-0019","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0959-440X(00)00175-5","article-title":"Integration of genome data and protein structures: prediction of protein folds, protein interactions and \u201cmolecular phenotypes\u201c of single nucleotide polymorphisms","volume":"11","author":"Sunyaev","year":"2001","journal-title":"Curr Opin Struct Biol"},{"key":"10.1002\/pbc.25552-BIB0020|pbc25552-cit-0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12094-010-0466-z","article-title":"Neuroblastoma in adolescents: Genetic and clinical characterisation","volume":"12","author":"Castel","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1002\/pbc.25552-BIB0021|pbc25552-cit-0021","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neo.2014.05.012","article-title":"Neuroblastoma after childhood: Prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration","volume":"16","author":"Berbegall","year":"2014","journal-title":"Neoplasia Jun"},{"key":"10.1002\/pbc.25552-BIB0022|pbc25552-cit-0022","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-4608(96)00300-7","article-title":"Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: Evidence for two deleted regions","volume":"96","author":"Marshall","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1002\/pbc.25552-BIB0023|pbc25552-cit-0023","first-page":"907","article-title":"Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma","volume":"57","author":"Takita","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0024|pbc25552-cit-0024","first-page":"3941","article-title":"Two regions of deletion in 9p23-24 in sporadic breast cancer","volume":"59","author":"An","year":"1999","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0025|pbc25552-cit-0025","first-page":"400","article-title":"Identification of three distinct tumor suppressor loci on the short arm of chromosome 9p in small cell lung cancer","volume":"57","author":"Kim","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0026|pbc25552-cit-0026","first-page":"141","article-title":"Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma","volume":"11","author":"Weilandt","year":"2014","journal-title":"Cancer Genom Proteom"},{"key":"10.1002\/pbc.25552-BIB0027|pbc25552-cit-0027","first-page":"2053","article-title":"No CDKN2 mutations in neuroblastomas","volume":"55","author":"Beltinger","year":"1995","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0028|pbc25552-cit-0028","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<570::AID-CNCR21>3.0.CO;2-0","article-title":"Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2\/MTS1\/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas","volume":"77","author":"Kawamata","year":"1996","journal-title":"Cancer"},{"key":"10.1002\/pbc.25552-BIB0029|pbc25552-cit-0029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-2744(199703)18:3<129::AID-MC1>3.0.CO;2-A","article-title":"Mutational analysis of the p16 gene in human neuroblastomas","volume":"18","author":"Castresana","year":"1997","journal-title":"Mol Carcinog"},{"key":"10.1002\/pbc.25552-BIB0030|pbc25552-cit-0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1203\/00006450-199801000-00021","article-title":"Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma","volume":"43","author":"Iolascon","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1002\/pbc.25552-BIB0031|pbc25552-cit-0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-4608(01)00640-9","article-title":"Two regions of deletion in 9p22-p24 in neuroblastoma are frequently observed in favorable tumors","volume":"135","author":"Giordani","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1002\/pbc.25552-BIB0032|pbc25552-cit-0032","first-page":"400","article-title":"Identification of three distinct tumor suppressor loci on the short arm of chromosome 9p in small cell lung cancer","volume":"57","author":"Kim","year":"1997","journal-title":"Cancer Res"},{"key":"10.1002\/pbc.25552-BIB0033|pbc25552-cit-0033","first-page":"395","article-title":"Chromosome 9p deletions in cutaneous malignant melanoma: the minimal deleted region involves markers outside the p16(CDK2) gene","volume":"57","author":"Puig","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1002\/pbc.25552-BIB0034|pbc25552-cit-0034","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07399","article-title":"Oncogenic mutations of ALK kinase in neuroblastoma","volume":"455","author":"Chen Y1","year":"2008","journal-title":"Nature"},{"key":"10.1002\/pbc.25552-BIB0035|pbc25552-cit-0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yexmp.2013.06.002","article-title":"ALK amplification and protein expression predict inferior prognosis in neuroblastomas","volume":"95","author":"Wang","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"10.1002\/pbc.25552-BIB0036|pbc25552-cit-0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma","volume":"45","author":"Sausen M1","year":"2012","journal-title":"Nat Genet"},{"key":"10.1002\/pbc.25552-BIB0037|pbc25552-cit-0037","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma","volume":"45","author":"Pugh TJ1","year":"2013","journal-title":"Nat Genet"},{"key":"10.1002\/pbc.25552-BIB0038|pbc25552-cit-0038","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF01570737","article-title":"Localization of multidrug resistance-associated DNA sequences to human chromosome 7","volume":"12","author":"Fojo","year":"1986","journal-title":"Somat Cell Mol Genet"},{"key":"10.1002\/pbc.25552-BIB0039|pbc25552-cit-0039","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/gcc.20496","article-title":"ArrayCGH-based classification of neuroblastoma into genomic subgroups","volume":"46","author":"Michels","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1002\/pbc.25552-BIB0040|pbc25552-cit-0040","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.27432","article-title":"Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma","volume":"131","author":"Coco","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/pbc.25552-BIB0041|pbc25552-cit-0041","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1200\/JCO.2009.26.7955","article-title":"Accumulation of segmental alterations determines progression in neuroblastoma","volume":"28","author":"Schleiermacher","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.25552","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.25552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T07:23:36Z","timestamp":1533540216000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pbc.25552"}},"subtitle":["Genetics of NB in AYA"],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.25552","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}